APA (7th ed.) Citation

U, M., S, B., I, C., C, C., G, C., G, d., . . . N, F. (2025). Next-generation sequencing methodologies to identify patients for targeted therapy: Focus on HR+/HER2- metastatic breast cancer. Pathologica, 117(6), 546. https://doi.org/10.32074/1591-951X-1531

Chicago Style (17th ed.) Citation

U, Malapelle, et al. "Next-generation Sequencing Methodologies to Identify Patients for Targeted Therapy: Focus on HR+/HER2- Metastatic Breast Cancer." Pathologica 117, no. 6 (2025): 546. https://doi.org/10.32074/1591-951X-1531.

MLA (9th ed.) Citation

U, Malapelle, et al. "Next-generation Sequencing Methodologies to Identify Patients for Targeted Therapy: Focus on HR+/HER2- Metastatic Breast Cancer." Pathologica, vol. 117, no. 6, 2025, p. 546, https://doi.org/10.32074/1591-951X-1531.